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Background. Mycobacterium abscessus has emerged as a major pathogen in cystic ﬁbrosis (CF) patients and has
been associated with poor clinical outcomes, particularly following lung transplant. We investigated the acquisition
of this bacterium in a cohort of pediatric CF patients.
Methods. Demographic and patient location data were used to uncover epidemiological links between patients
with genetically related strains of M. abscessus that had been previously typed by variable-number tandem repeat
proﬁling. Whole-genome sequencing was applied to 27 M. abscessus isolates from the 20 patients in this cohort
to provide deﬁnitive data on the genetic relatedness of strains.
Results. Whole-genome sequencing data demonstrated thatM. abscessus isolates from 16 patients were unrelat-
ed, differing by at least 34 single-nucleotide polymorphisms (SNPs) from any other isolate, suggesting that indepen-
dent acquisition events have occurred. Only 2 clusters of very closely related (<25 SNPs) isolates from different
patients were seen. The ﬁrst cluster contained 8 isolates, differing by a maximum of 17 SNPs, from a sibling pair
who had intense exposure to each other both inside and outside the hospital. The second cluster contained 3 isolates,
differing by a maximum of 24 SNPs, from 2 individuals with no apparent epidemiological links.
Conclusions. We have not demonstrated cross-transmission ofM. abscessus within our hospital, except between
1 sibling pair. Alternative routes of acquisition of M. abscessus infection, in particular the environment, require
further investigation.
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Mycobacterium abscessus has emerged as a major patho-
gen in cystic ﬁbrosis (CF) patients and has been associ-
ated with poor clinical outcomes, particularly following
lung transplant [1–3].Mycobacterium abscessus is resis-
tant to most classes of antibiotics [4, 5]. Macrolide resis-
tance is either due to mutations in the rrl gene or the
presence of an inducible ribosomal RNA methylase
gene, erm(41) [6–8].
Mycobacterium abscessus is a single species that en-
compasses 3 subspecies (M. abscessus subsp abscessus,
M. abscessus subsp massiliense, and M. abscessus
subsp bolletii) [8–11]. These 3 subspecies have been
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associated with varying clinical outcomes [8, 12–14]. Accurate
identiﬁcation can generally be achieved by sequencing multi-
ple gene targets [15]. Variable-number tandem repeat (VNTR)
proﬁling can further differentiate isolates [9, 16] and, when
applied to our cohort, showed that the majority of chronically
infected patients were infected with 1 of 2 dominant strains. [9].
Whole-genome sequencing can provide more deﬁnitive data
on the relatedness of isolates. Several publications have reported
whole-genome sequences from a single M. abscessus complex
isolate [17–20] or several isolates from a single patient [21].
Whole-genome sequences of M. abscessus subsp massiliense
isolates from a cohort of adults with CF provided the ﬁrst evi-
dence that patient-to-patient spread can occur [10].
We describe the dynamics of acquisition of M. abscessus in a
cohort of pediatric CF patients, using epidemiological and clin-
ical data to uncover evidence of cross-transmission events and
whole-genome sequencing to establish the resolution of the pre-
viously published VNTR typing scheme. Ultimately, this will
lead to a better understanding of the impact of particular strains
on clinical outcomes, especially following lung transplant.
MATERIALS AND METHODS
Patients and Microbiological Data Collection
Great Ormond Street Hospital is a large regional referral center
for pediatric CF patients, including those patients for whom the
hospital is their main CF clinic and patients from other centers
undergoing assessment and then being listed for lung transplant
(Table 1). All patients seen as outpatients or admitted to wards
undergo regular respiratory microbiological diagnostic investi-
gations, including speciﬁc stain and culture for mycobacteria on
both sputum and bronchoalveolar lavage samples (which are
performed at least on an annual basis).
Demographic and patient location data were extracted from
the patient administration system and microbiological data
from the laboratory information management system using
SQL (structured query language) databases and Excel spread-
sheets. Electronic patient records were used to capture all inpa-
tient and outpatient episodes including location (general CF
clinics, lung function testing, inpatient ward, and bed-days ad-
mitted). Additional sources of information included CF and
transplant databases. Clinical case-note review was used to ver-
ify location, admission data, and clinical/radiological evidence
of nontuberculous mycobacteria infection using American
Thoracic Society consensus guidelines [5]. All investigations
were performed in accordance with the hospital’s research gov-
ernance policies and procedures. We sought and obtained spe-
ciﬁc informed consent in 2 instances where patients had moved
from our center to an adult CF center.
For patients who had isolated M. abscessus for the ﬁrst time
after initial contact with the hospital, all outpatient and inpatient
admission episodes and cumulative bed-days were captured up to
the date of their initial culture with M. abscessus. Exposure of
these M. abscessus–naive patients was deﬁned as being at the
same time and same location as another patient known to be in-
fected with M. abscessus. For comparison purposes, basic demo-
graphic data were collected on all patients who had isolated
Pseudomonas aeruginosa for the ﬁrst time after initial contact
with our hospital. Surveillance data on P. aeruginosa have been
prospectively gathered and stored on a database since 1994.
The project was registered as a service evaluation.
Data Analysis
Graphs and (where appropriate) statistical analysis were generated
using GraphPad Prism software version 6.03. Advice on statistical
analysis of epidemiological exposure data was provided by the De-
partment of Paediatric Epidemiology and Biostatistics at the Insti-
tute of Child Health. Where statistical analysis was performed,
nonparametric tests were utilized (Mann–Whitney U test for un-
paired data and Wilcoxon signed-rank tests for paired data).
Whole-Genome Sequencing
Twenty-seven M. abscessus isolates from 20 pediatric CF pa-
tients attending either CF or transplant clinics at our hospital
between January 2004 and December 2011 were analyzed by
whole-genome sequencing. All isolates had previously been
identiﬁed to subspecies level by sequencing of hsp65 and rpoB
gene targets [15] and typed by VNTR proﬁling [9]. DNA was
extracted from isolates as previously described [9], and the con-
centration was determined using a Qubit high-sensitivity (HS)
assay kit (Life Technologies). Two hundred ﬁfty nanograms of
DNA was sheared on the Covaris S2 (duty cycle, 5%; intensity,
4; cycles per burst, 200; time, 90 seconds) before undergoing
library preparation with the NEBNext DNA Library Prep Mas-
ter Mix Set for Illumina (New England Biolabs) combined with
12 cycles of enrichment polymerase chain reaction with multi-
plex adapters. During library preparation, libraries were size-
selected to 500 bp using Ampure XP beads (Beckman). Final
libraries were quantiﬁed using the Qubit HS DNA assay, and
absence of adapter-dimer was conﬁrmed using the Bioanalsyer
HS DNA Chip (Agilent). Libraries were equimolar pooled, and
12 pM was loaded onto an Illumina MiSeq to undergo 250 bp
paired-end sequencing with v2 chemistry. The short reads from
these studies are deposited in the short-read archive of the
European Nucleotide Archive in the project PRJEB6776.
Sequence Data Analysis
Whole-genome phylogenetic analysis was performed using the
sequence data from this study and from M. abscessus isolates
from adult patients described in the study by Bryant et al
[10], as deposited in the European Nucleotide Archive under
study accession number ERP001039.
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Table 1. Twenty Patients With Cystic Fibrosis From Whom Mycobacterium abscessus Was Isolated
Patient Subspecies VNTR Cluster Sex CF Genotype
Clinical
Diagnosis
of NTM
Infection
Proportion
of Sputum/
BAL AAFB
Positive
No. of
Positive
M. abscessus
Cultures
Specific
M. abscessus
Antimicrobial
Treatment
Given
Age at First
M. abscessus
Isolate, y
Years Between
First M.
abscessus
Isolate and
Contact With
Study Center
Infection
Status at
First Contact
to GOSH
Main CF
Attending
Center/Main
CF Center
UK Residence
HPU
2 ABS VNTR I F p.Phe508del/p.Phe508del Likely 6/32 6 Y 13.59 0 Already
Infected
South of
England
Surrey and Sussex
8 ABS VNTR I M p.Phe508del/p.Phe508del Likely 7/20 10 Y 10.29 10.04 Naive Study center South Midlands
and
Hertfordshire
9 ABS VNTR I F p.Phe508del/p.Trp1089X Likely 22/35 20 Y 10.93 0 Already
Infected
London
(other)/
study
center
Northwest London
10 ABS VNTR I M p.Phe508del/p.Phe508del Likely 5/17 6 Y 13.36 4.97 Naive Study center South Midlands
and
Hertfordshire
21 ABS VNTR I M p.Phe508del/p.Phe508del Likely 4/5 5 Y 15.15 11.97 Naive Study center South Midlands
and
Hertfordshire
3 ABS VNTR II F p.Phe508del/p.Phe508del Likely 6/25 11 Y 11.33 0 Already
Infected
North of
England
Cumbria and
Lancashire
18 ABS VNTR II M p.Phe508del/p.Gly551Asp Likely 53/62 40 Y 5.90 3.79 Naive Study center Northwest London
19 ABS VNTR II F p.Phe508del/p.Phe508del Likely 0/4 1 Y 17.25 16.18 Naive Study center Northwest London
22 ABS VNTR II F Delta F508/I507/Delta F508/I507 Likely 5/25 10 Y 15.05 14.24 Naive Study center Northwest London
11 ABS Unique F c.2988+1G>A/p.Tyr913X Likely 0/40 3 Y 13.76 13.04 Naive Study center Northeast and
North- central
London
15 ABS Unique F p.Phe508del/c.1585–1G>A Unlikely 4/6 5 N 10.99 10.87 Naive Study center Anglia
17 ABS Unique M p.Phe508del/p.Phe508del Unlikely 1/13 1 No 14.07 13.81 Naive Study center Southeast London
24 ABS Unique F UK Likely 1/15 1 Y 13.27 0 Already
Infected
London
(other)
South Midlands
and
Hertfordshire
27 ABS Unique F p.Phe508del/p.Phe508del Likely 2/21 2 Y 14.86 5.37 Naive Study center South Midlands
and
Hertfordshire
30 ABS Unique F p.Phe508del/p.Phe508del Likely 3/10 4 Y 14.99 14.64 Naive Study center Essex
7 MAS VNTR III F p.Phe508del/p.Phe508del Likely 3/3 3 Y 14.49 0 Already
Infected
Midlands West Midlands
West
23 MAS VNTR III F p.Phe508del/p.Phe508del Likely 25/40 30 Y 6.97 5.64 Naive Study center South Midlands
and
Hertfordshire
14 MAS Unique F p.Gly551Asp/c.2052delA Likely 0/8 1 Y 14.29 0 Already
Infected
Wales South Wales
28 MAS Unique F p.Phe508del/p.Phe508del Likely 1 1 Y 14.09 0 Already
Infected
Midlands West Midlands
East
1 BOL Unique F p.Phe508del/p.Phe508del Likely 1/14 1 Y 10.08 0 Already
Infected
London
(other)
Northeast and
North-central
London
Clinical and radiological diagnosis of likely NTM infection with clinician decision to treat with long-term antibiotics considered active against M. abscessus was recorded in patient records.
Abbreviations: AAFB, acid-alcohol fast bacilli; ABS,Mycobacterium abscessus subsp abscessus; BAL, bronchoalveolar lavage; BOL,Mycobacterium abscessus subsp bolletii; CF, cystic fibrosis; GOSH, Great Ormond
Street Hospital; HPU, Health Protection Unit; MAS, Mycobacterium abscessus subsp massiliense; NTM, nontuberculous mycobacteria; VNTR, variable-number tandem repeat.
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The short reads were mapped to the reference ATCC 19977
(accession number CU458896) using BWA-MEM 0.7.5.a [22]
and the default parameters. The sequence alignment map out-
put from BWA was sorted and indexed to produce a binary
alignment map (BAM) using Samtools 0.1.18 [23].The Genome
Analysis Toolkit 2 [24] was used to create a variant call format
(VCF) ﬁle for each sequenced isolate using the BAM ﬁles as
input and specifying diploid mode when calling variants. Var-
iants within the VCF ﬁles were parsed to retain high-quality sin-
gle-nucleotide polymorphisms (SNPs) based on the following
conditions: DP (depth) ≥5, AD ratio (ratio between variant
base and alternative bases) ≥0.8, MQ (mapping quality score)
≥30, ratio of number of reads with MQ0 (mapping quality of
0) to total number of reads ≤0.05, and distance to nearest
SNP >10. All positions that fulﬁlled these criteria in >0.9 of
the samples were joined to produce a multiple fasta format
ﬁle where the sequence for each strain consists of the concate-
nated variants. This ﬁle was used as an input to generate a max-
imum likelihood tree using RAxML [25] with the following
parameters: –m (substitutionModel) GTRCAT, –b (bootstrap-
RandomNumberSeed) 12345, -# (NumberOfRuns) 100, –c
(NumberOfCategories) 25.
Multilocus sequence types (MLSTs) were identiﬁed by map-
ping the reads against all M. abscessus allele variants held in the
Institut Pasteur MLST database (http://www.pasteur.fr/recherche/
genopole/PF8/mlst/) using a modiﬁcation of the short-read
sequence typing [26].
Antibiotic resistance analysis was performed by searching for
SNPs previously discovered to be responsible for resistance
mutations within the coding sequence of rrl and both the cod-
ing sequence and 126-bp upstream regulatory region of erm(41)
[6]. Trimmed reads were mapped to the rrl and erm(41) gene
sequences from the genome sequence of M. abscessus strain
ATCC 19977 using bowtie2 version 2.1 (http://bowtie-bio.
sourceforge.net/bowtie2/index.shtml). The resulting BAM ﬁle
was converted to pileup format using samtools and the output
parsed to determine the nucleotide base at the known drug-
resistance locations. To generate a phylogenetic tree based on
the rrl and erm(41) genes, the pileup format was converted to
form a consensus sequence for each sample, aligned using mus-
cle [27], and a maximum likelihood tree was created using Fast-
Tree [28].
RESULTS
Clinical and Microbiological Characteristics of
M. abscessus–Infected CF Patients
In patients from whom M. abscessus was isolated for the ﬁrst
time, a number of observations were apparent. When compared
with a larger cohort of M. abscessus–negative CF patients
(n = 122) who acquired P. aeruginosa for the ﬁrst time after con-
tact with the hospital, children who acquired M. abscessus were
signiﬁcantly older (P = .0001, Mann–Whitney U test; Figure 1).
The median age for acquiring P. aeruginosawas 4.35 years com-
pared with a median age of ﬁrst acquisition of M. abscessus of
14.07 years (P = .005, Wilcoxon signed-rank test; Table 1 and
Figure 1). The median age difference in years between ﬁrst P.
aeruginosa isolation and ﬁrst M. abscessus isolation was 7.56
Figure 1. Comparison of age of acquisition of Pseudomonas aeruginosa and Mycobacterium abscessus in cohort of pediatric cystic ﬁbrosis patients. A,
Age at ﬁrst acquisition of P. aeruginosa in M. abscessus–negative patients (n = 122) vs age of acquisition of M. abscessus (P < .0001, Mann–Whitney U
test). B, Age of acquisition of P. aeruginosa vs acquisition of M. abscessus in all 12 patients who acquired M. abscessus after ﬁrst contact with hospital
(P = .001, Wilcoxon signed-rank test). C, Time in years after ﬁrst contact with hospital and ﬁrst acquisition of P. aeruginosa vs acquisition of M. abscessus
(n = 12; P = .002, Wilcoxon signed-rank test).
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years (interquartile range, 5.18–11.00 years). Taken together, in
this single but large regional referral center, infection with P.
aeruginosa always precedes M. abscessus infection, which usu-
ally occurs in the early to middle teenage years.
Mycobacterium abscessus strains clustered by VNTR proﬁle
(VNTR I, VNTR II, or VNTR III) or had unique VNTR pro-
ﬁles. Among the 12 patients who acquired M. abscessus for
the ﬁrst time during contact with our hospital, 11 acquired
M. abscessus subsp abscessus strains (3 VNTR I, 3 VNTR II,
and 5 with unique VNTR proﬁles) [9], and 1 individual ac-
quired M. abscessus subsp massiliense (Table 1). After consult-
ing with expert statistical colleagues, we concluded that there
were insufﬁcient numbers in each VNTR-deﬁned outcome
group to make statistically robust comparisons based on multi-
ple comparisons of exposure to ward environments or among
patients. Despite the relatively low numbers of deﬁned acquisi-
tion events, we were able to make a number of observations.
Patient-to-Patient Contact of M. abscessus–Infected CF Patients
We analyzed the strength of exposure of patients who acquired
M. abscessus after exposure to other patients with M. abscessus
of any subspecies and VNTR proﬁle. First, taking the patients
(n = 3) who acquired VNTR I strains, there was minimal expo-
sure to patients already infected with a VNTR I strain, either as
an outpatient or as an inpatient. In contrast, patients who ac-
quired VNTR I strains were exposed on a number of occasions
both as inpatients and outpatients to other patients already in-
fected with VNTR II strains and strains with unique VNTR pro-
ﬁles (Figure 2A and 2D). Where patients acquired VNTR II
strains (n = 3), there was more intense exposure to patients
with VNTR II strains (in particular, between patients 18 and
19) in both outpatient and inpatient settings than to patients
with VNTR I strains; however, exposure to patients with strains
that had a unique VNTR proﬁle was similarly intense (Figure 2B
and 2E ). Patients who acquired strains with a unique VNTR
Figure 2. Exposure of patients who ﬁrst acquired Mycobacterium abscessus after contact with our center to other M. abscessus-infected patients. Ex-
posure of patients who acquiredM. abscessus subsp abscessus (MA) variable-number tandem repeat (VNTR) I (n = 3; A and D), MAVNTR II (n = 3; C and E ),
and MAVNTR unique strains (n = 5; C and F ) to other patients already infected with MAVNTR I, VNTR II, VNTR unique, andM. abscessus subspmassiliense
strains. A–C, Total number of bed-days on the same ward at the same time that each patient was with other M. abscessus-infected patients. C–E, Total
number of outpatient episodes where patients were with other M. abscessus-infected patients. Abbreviation: OPD, outpatients department.
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proﬁle (n = 5) were also exposed on a number of occasions, in
both outpatient and inpatient environments, to patients infect-
ed with strains with different VNTR proﬁles, including VNTR I
and VNTR II strains (Figure 2C and 2F).
Whole-Genome Sequencing of M. abscessus Isolates
Whole-genome sequences were obtained from 27 M. abscessus
isolates in this study. These and sequences from the study by
Bryant et al [10] were processed to produce a multiple fasta
ﬁle, which was used to generate a tree. The fasta ﬁle recorded
a total of 133 683 variant positions. The maximum likelihood
tree showed 3 distinct clades corresponding to the 3 subspecies.
Twenty isolates from this study wereM. abscessus subsp absces-
sus, 6 wereM. abscessus subspmassiliense, and 1 wasM. absces-
sus subsp bolletii. Sixteen isolates were assigned to 1 of 4 clades.
A further 9 isolates that were not closely grouped with >1 isolate
were not assigned to a clade (Figure 3). Two isolates (27–313
and 28–319) did not produce sufﬁcient read-depth to be includ-
ed in the maximum likelihood tree.
Within clade 1, there were 152 SNPs; the minimum distance
between any an isolate from this study and any other was 38
SNPs. Within clade 2, there were 157 SNPs. Isolates 18–114,
18–531, 18–362, 7_a, 7_b, 7_c, 7_d, 19–825, and 18–169 dif-
fered by 17 SNPs, and the smaller subset of 18–169, 19–825,
7_a, 7_b, 7_c, and 7_d differed by just 5 SNPs. Within clade
3, there were 1328 SNPs; the minimum distance between an iso-
late from this study and any other was 43 SNPs. Within clade 4,
there were 308 SNPs. Isolates 8–768 and 8–170 were 2 SNPs dif-
ferent. Isolates 10–994, 21–468, and 15_a differed by 24 SNPs.
Apart from these, the minimum distance between any isolate
from this study and any other was 34 SNPs (Figure 4).
MLST and Resistance Mutations
MLSTs were deduced from the whole-genome sequences of all
isolates in this study. All VNTR 1 strains were sequence type
ST-26 and fell into sequence clade 4. All VNTR II strains were
ST-1 and fell into sequence clade 2. The VNTR III strains had 2
different MLST types (ST-48 and ST-23) and fell into sequence
clade 1 or no clade. All other strains had a unique VNTR proﬁle
and MLST type and did not fall into any sequence clade (Table 2).
Mutations in the rrl and erm(41) genes, known to cause an-
timicrobial resistance, were also examined. None of the VNTR I
Figure 3. A maximum likelihood tree based on single-nucleotide polymorphisms in shared regions from the whole genome of Mycobacterium abscessus
isolates from this study (dark blue text) and from the study described by Bryant et al [10] (black text). Three major lineages representing the M. abscessus
subsp massiliense, bolletti, and abscessus are shaded in orange, blue, and green, respectively. The scale bar represents the number of substitutions per site
across 133 683 variable sites.
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or VNTR II strains had erm(41) mutations and therefore had a
predicted phenotype of inducible macrolide resistance. All M.
abscessus subsp massiliense strains had a truncated erm(41) se-
quence, no resistance-associated rrl mutations, and were pre-
dicted to be macrolide susceptible. Four M. abscessus strains
with unique VNTR proﬁles had no resistance-associated rrl
mutations and had the erm(41)mutation (T28C) that predicts
macrolide susceptibility (Table 2). A phylogenetic tree generat-
ed from the rrl and erm(41)sequences clustered isolates iden-
tically to the trees generated from whole-genome sequences.
Two isolates that did not produce sufﬁcient read-depth to be in-
cluded in the whole-genome analysis were included in this tree
(Supplementary Figure).
DISCUSSION
The purpose of this retrospective cohort study of M. abscessus
infection in pediatric CF patients was to explore the evidence for
cross-infection between patients using a combination of epide-
miology, VNTR proﬁling, and whole-genome sequencing.
Epidemiological data were used to investigate the intensity of
exposure between patients with strains that were identical by
VNTR proﬁling and strains with different VNTR proﬁles [9].
We hypothesized that if cross-transmission had occurred, we
were likely to see more intense exposure prior to ﬁrst detection
of a VNTR I or VNTR II strain with a strain from the same clus-
ter compared with exposure to strains from another cluster or
Figure 4. Subtrees from the maximum likelihood tree in Figure 3 representing detailed views of 4 clades where >2 isolates from this study were clustered.
Where there are groups of isolates only from the study by Bryant et al [10], these are collapsed and displayed as triangles because they do not represent
new data. Isolates from this study are shown in dark blue, and those from the study described by Bryant et al in black. The scale bar represents the number
of substitutions per site.
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unique strains. There was little evidence of transmission of M.
abscessus as a result of contact with the hospital. Only 2 patients
(18 and 19), a sibling pair who both acquired VNTR II strains,
had frequent exposure to each other in outpatient environments
and at home.
Whole-genome sequencing data have provided a more accu-
rate basis for assessing the degree of genetic similarity between
isolates and have conﬁrmed that VNTR proﬁling is an accurate
method for identifying genetically related strains. Isolates with
identical VNTR proﬁles were also of the same MLST type and
belonged to the same whole-genome sequence clade, with the ex-
ception of 3M. abscessus subspmassiliense isolates (Figure 3 and
Table 2). All isolates with either the VNTR I or VNTR II proﬁle
(ST-26 and ST-1) were predicted to have a phenotype of induc-
ible macrolide resistance. These are the dominant VNTR types in
our patient cohort, and we have previously suggested a link with
chronic infection [9]. Moreover, ST-1 and ST-26 are global line-
ages that appear to be successful clones [29]. Indeed, infections
with strains that have inducible resistance to macrolides would
be signiﬁcantly harder to treat and therefore more likely to estab-
lish chronic infections [30].However, it is possible that other pa-
rameters are important, such as expression of virulence factors,
bioﬁlm formation, adaptation to the CF microenvironment,
and host–pathogen interactions [31], all of which warrant further
study. The ﬁnding that all the patients who acquiredM. abscessus
were already infected with P. aeruginosa is noteworthy, although
the reasons for this are unclear. It is possible that more aggressive
antimicrobial therapy associated with chronic P. aeruginosa
infection could play a role; however, the precise mechanism is
as yet unknown and warrants further study.
Table 2. Genotypic Data for All 27 Mycobacterium abscessus Isolates in This Study
Isolate
Date
Isolated Subspecies
VNTR
Profile MLST Type
Sequence
Clade
erm(41)
Mutation
rrl
Mutation
Predicted Macrolide
Resistance
Phenotype
15–313 Jun 2006 ABS Unique ST-122 3 T28C None Susceptible
24–878 Mar 2009 ABS Unique Novel allele None none None Inducible resistance
17–257 Apr 2009 ABS Unique Novel ST 3 T28C None Susceptible
27–313 Dec 2012 ABS Unique ST-33 Not availablea none None Inducible resistance
30–578 Jun 2012 ABS Unique Novel ST None none None Inducible resistance
11–067 Oct 2008 MAS Unique ST-117 None Trunc158–430 None Susceptible
11–618 May 2012 ABS Unique Novel allele None None None Inducible resistance
2–520 Jan 2009 ABS VNTR I ST-26 4 None None Inducible resistance
8–046 Jun 2007 ABS Unique Novel ST None T28C None Susceptible
8–170 Oct 2009 ABS VNTR I ST-26 4 None None Inducible resistance
8–768 May 2012 ABS VNTR I ST-26 4 None None Inducible resistance
9–847 Nov 2009 ABS VNTR I ST-26 4 None None Inducible resistance
21–468 Oct 2009 ABS VNTR I ST-26 4 None None Inducible resistance
10–994 Feb 2011 ABS VNTR I ST-26 4 None None Inducible resistance
18–169 Jun 2007 ABS VNTR II ST-1 2 None None Inducible resistance
18–114 Mar 2008 ABS VNTR II ST-1 2 None None Inducible resistance
18–362 Mar 2010 ABS VNTR II ST-1 2 None None Inducible resistance
18–531 Jan 2012 ABS VNTR II ST-1 2 None None Inducible resistance
3–390 Jul 2009 ABS VNTR II ST-1 2 None None Inducible resistance
22–071 Feb 2009 ABS VNTR II ST-1 2 None None Inducible resistance
19–825 Jun 2007 ABS VNTR II ST-1 2 None None Inducible resistance
14–907 Apr 2005 MAS Unique ST-69 None Trunc158–430 None Susceptible
7–983 Apr 2009 MAS VNTR III ST-23 1 Trunc158–430 None Susceptible
23–476 Feb 2009 MAS VNTR III ST-48 None Trunc158–430 None Susceptible
23–816 Nov 2011 MAS VNTR III ST-48 None Trunc158–430 None Susceptible
28–319 Jun 2011 MAS Unique ST-37 Not availablea Trunc158–430 None Susceptible
1–873 Dec 2004 BOL Unique Novel ST None None None Inducible resistance
Sequence clade, MLST types, erm(41) mutations, and rrl mutations were all deduced from the genome sequencing data.
Abbreviations: ABS, Mycobacterium abscessus subsp abscessus; BOL, Mycobacterium abscessus subsp bolletii; MAS, Mycobacterium abscessus subsp
massiliense; MLST, multilocus sequence type; ST, sequence type; VNTR, variable-number tandem repeat.
a Insufficient sequence reads to determine sequence clade.
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Whole-genome sequence data provided greater resolution
than either VNTR proﬁling or MLST, differentiating isolates
within each of the 4 clades. Bryant et al [10] described different
modes of similarity where those isolates belonging to a “related”
cluster are <25 SNPs different. Using this cutoff, there are only 2
clusters with isolates from >1 patient in our data. The ﬁrst clus-
ter contains 4 isolates from patient 18 and 1 isolate from patient
19 (sibling). There were also 4 sequences (7 a–d) from Bryant
et al [10], and we have conﬁrmed that these were also isolates
from patient 19, who was transferred to the adult service.
These isolates were identical or virtually identical, differing by
a maximum of 17 SNPs in patient 18 over a 5-year period. Pa-
tients 18 and 19 had a great deal of exposure to each other, par-
ticularly at home. Cross-transmission ofM. abscessus is likely to
have occurred, although, interestingly, the older sibling acquired
M. abscessus 11 years after the younger sibling. The second clus-
ter contains isolates from patients 10 and 21 (this study) and 15
(Bryant et al [10]), and we have conﬁrmed that patient 10 and
15 are the same individual. Patients 10 and 21 acquired M. ab-
scessus at a similar time, after their ﬁrst contact with our center.
However, the epidemiological data in this study did not show
any contact between these 2 individuals within the hospital en-
vironment. Furthermore, they did not attend the same local
hospital, outreach clinics, or school and, to the best of our
knowledge, did not know each other socially. This suggested
that cross-transmission between these 2 patients was unlikely
and that these individuals had acquired highly genetically relat-
ed strains by another route.
Isolates from the remaining 16 patients in this study differed
by at least 34 SNPs from each other, which further suggested that
cross-transmission was uncommon in this pediatric CF cohort.
This conclusion has been reached previously by genotyping of
M. abscessus isolates from CF patients at a single center [32].
However, this is in contrast to a recent study that demonstrated
person-to-person spread of M. abscessus subsp massiliense be-
tween adult CF patients [10]. It is not yet clear why this difference
is seen. It is possible that M. abscessus subsp massiliense is more
transmissible, or that adults have more prolonged or intense ex-
posures or shed a higher load of bacteria into the environment,
making transmission more likely. Differences in infection control
practices between centers could also explain why we have seen
little evidence of person-to-person spread. Another potential
route of acquisition of M. abscessus is a common environmental
source. A recent publication demonstrated that strains isolated
from potable water were genetically similar to patient isolates
[33, 34]. We suggest that a better understanding of the role of
the environment in the acquisition of M. abscessus infection is
critical and has not been adequately investigated.
In conclusion, we could not demonstrate cross-transmission of
M. abscessus within our hospital, except between 1 sibling pair
that had intense exposure both in the hospital and, perhaps
more importantly, the home environment. Two patients were in-
fected with highly genetically similar strains but appeared to be
epidemiologically unrelated. The role of the environment in the
acquisition ofM. abscessus infection requires further investigation.
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